Efficacy and safety of pazopanib in patients with advanced and/or metastatic renal cell carcinoma (mRCC) after previous checkpoint inhibitor treatment

@inproceedings{Powles2018EfficacyAS,
  title={Efficacy and safety of pazopanib in patients with advanced and/or metastatic renal cell carcinoma (mRCC) after previous checkpoint inhibitor treatment},
  author={Thomas B Powles and Emiliano Calvo and Viktor Gr{\"u}nwald and Daniel Y. C. Heng and David L. Michaelson and Luca Dezzani and Yulia Hirschberg and Sandip Acharya and St{\'e}phane Oudard},
  year={2018}
}

Similar Papers

Loading similar papers…